Advertisement

Topics

Cystic Fibrosis Enters the Proteomics Scene Company Profile

23:03 EDT 23rd September 2017 | BioPortfolio

As a continuation to genomic research, proteomics now offers the unique advantage to examine global alterations in the protein expression patterns of CF cells and tissues. The systematic use of proteomics should ultimately result in the finding of new prognostic markers...


News Articles [988 Associated News Articles listed on BioPortfolio]

Clinical trials pave way to new cystic fibrosis drug

Imagine breathing through only a tiny straw. That is what life is like for people with cystic fibrosis, which includes about 30,000 people in the United States, making cystic fibrosis the most common ...

Cystic fibrosis study offers new understanding of silent changes in genes

Researchers studying the root cause of cystic fibrosis have made a major advance in our understanding of silent gene changes with implications for the complexity of cystic fibrosis. The findings are p...

Catabasis Pharmaceuticals Presents New Data for CAT-5571 as a Novel Potential Oral Treatment for Cystic Fibrosis at the 40th European Cystic Fibrosis Society Conference

Thursday, June 8th 2017 at 3:00pm UTC — CAT-5571 Restores Autophagy, a Host Defense Mechanism, Which Is Known to be Impaired in Cystic Fibrosis — — Data Demonstrate Improved Intracel...

Proteostasis Therapeutics files IND for PTI-808, cystic fibrosis potentiator

Proteostasis Therapeutics, a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by dysfunctional protein processing such as cystic fibrosis (CF), announced that ...

Vertex gains reimbursement agreement in Italy for cystic fibrosis drug Orkambi

Vertex Pharmaceuticals announced that the Italian Medicines Agency (Agenzia Italiana del Farmaco, or AIFA) has agreed to reimburse Orkambi (lumacaftor/ivacaftor), the first medicine to treat the under...

Bureaucratic barriers to cystic fibrosis treatment in USA

The Cystic Fibrosis Engagement Network, a project of the Alliance for Patient Access, today released…

FDA Expands Approval of Vertex’s Kalydeco to Treat Additional Mutations of Cystic Fibrosis

BOSTON–(BUSINESS WIRE)– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved KALYDECO® (ivacaftor) for use in p...

FDA Approves Vertex’s Kalydeco for 600+ Cystic Fibrosis Patients with One of Five Residual Mutations

BOSTON–(BUSINESS WIRE)– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved KALYDECO® (ivacaftor) for use ...

PubMed Articles [1651 Associated PubMed Articles listed on BioPortfolio]

End-of-life practice patterns at U.S. adult cystic fibrosis care centers: A national retrospective chart review.

There are many challenges to providing end-of-life care (EOLC) to people with cystic fibrosis (CF).

Pain is an underestimated symptom in cystic fibrosis.

Life expectancy is increasing in cystic fibrosis and new aspects of the disease have to be taken into account in cystic fibrosis care.

Association between glucose intolerance and bacterial colonisation in an adult population with cystic fibrosis, emergence of Stenotrophomonas maltophilia.

Diabetes is common in cystic fibrosis (CF). Glucose can be detected in the airway when the blood glucose is elevated, which favours bacterial growth. We investigated the relationship between dysglycem...

The impact of cystic fibrosis on work attendance and performance in adults living in rural and remote Western Australia.

The changing face of nutrition in cystic fibrosis.

Clinical Trials [1247 Associated Clinical Trials listed on BioPortfolio]

Miglustat / OGT 918 in the Treatment of Cystic Fibrosis

Cystic fibrosis is a genetic disease caused by mutation of the cystic fibrosis transmembrane conductance regulator (CFTR). The purpose of the study is to investigate the effects of miglust...

Exercise-Induced Bronchospasm in Cystic Fibrosis

Exercise is an important clinical feature in cystic fibrosis. Better exercise capacity has been associated with better patient outcomes and quality of life. Exercise-induced bronchospasm...

Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis

OBJECTIVES: Evaluate the efficacy and safety of lipid-mediated transfer of the cystic fibrosis transmembrane conductance regulator gene to nasal epithelium in patients with cystic f...

Study of Uridine Triphosphate (UTP) as an Aerosol Spray for Cystic Fibrosis

OBJECTIVES: I. Determine the stability of uridine triphosphate (UTP) and examine the metabolism of exogenous nucleotides on airway epithelial surfaces in patients with cystic fibrosis. ...

Determination of the Predictive Factors in the Reversibility or the Aggravation in the Disorders of the Glucose Metabolism in Cystic Fibrosis Patients

For some years, the investigators observe an increase of the arisen of diabetes in cystic fibrosis patients However, this diabetes may be reversible. The investigators speak about " Cystic...

Companies [281 Associated Companies listed on BioPortfolio]

Cystic Fibrosis Enters the Proteomics Scene

As a continuation to genomic research, proteomics now offers the unique advantage to examine global alterations in the protein expression patterns of CF cells and tissues. The systematic use of proteo...

Cystic Fibrosis Foundation

The Cystic Fibrosis Foundation is the world's leader in the search for a cure for cystic fibrosis. The Foundation funds more CF research than any other organization and nearly every CF drug available ...

Cystic Fibrosis Foundation, Northern Ohio Chapter

The Northern Ohio Chapter of the Cystic Fibrosis Foundation works to help develop a means to control and cure cystic fibrosis and to improve the lives of those with the dis...

Cystic Fibrosis Trust

•        Cystic fibrosis is chronically misunderstood, kills thousands worldwide and is carried unknowingly in the genes of millions. It's often invisible...

New Lung Associates

New Lung Associates is a pulmonary group of physicians leading the Lung Transplant Program and the Adult Cystic Fibrosis Program at Tampa General Hospital, a 988-bed acute care ho...

More Information about "Cystic Fibrosis Enters the Proteomics Scene" on BioPortfolio

We have published hundreds of Cystic Fibrosis Enters the Proteomics Scene news stories on BioPortfolio along with dozens of Cystic Fibrosis Enters the Proteomics Scene Clinical Trials and PubMed Articles about Cystic Fibrosis Enters the Proteomics Scene for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cystic Fibrosis Enters the Proteomics Scene Companies in our database. You can also find out about relevant Cystic Fibrosis Enters the Proteomics Scene Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record